Research guide / Epithalon
What is Epithalon? A Research Guide to Epitalon.
Updated October 2026 · 8 minute read
Epithalon, also spelled Epitalon, is a short synthetic peptide of four amino acids developed in St Petersburg in the 1980s. It is best known from laboratory studies on telomerase and cellular ageing. This guide covers where it came from, what the studies found, and why the human evidence remains thin.
01 / Overview
What is Epithalon?
Epithalon is the tetrapeptide alanine-glutamic acid-aspartic acid-glycine (Ala-Glu-Asp-Gly). A 2020 review by Vladimir Khavinson's group describes it as a synthetic version of a peptide sequence they identified in epithalamin, an extract of the pineal gland that they studied for several decades.[1]
A 2025 review in the International Journal of Molecular Sciences describes Epithalon as one of the most-cited of the so-called peptide bioregulators: short peptides proposed to interact with DNA and influence gene activity in specific tissues.[5]
Because the sequence is short and simple, it is easy to make and analyse, which is one reason it has stayed in the laboratory literature for decades.
02 / Mechanism
How is Epithalon thought to work?
A 2003 study reported that Epithalon caused changes in chromatin, the packaging around DNA, in white blood cells from older donors, making some regions more accessible. The authors proposed this as a way short peptides might influence gene activity.[2]
A 2004 cell-culture study reported that adding Epithalon to human fibroblasts increased telomerase activity and telomere length, and that the treated cells kept dividing beyond their usual limit. Telomeres are the protective caps at the ends of chromosomes that shorten as cells divide.[3]
These are laboratory findings in cells. How, or whether, they translate to whole organisms is a separate question.
03 / Published evidence
What does the evidence actually show?
In a 2003 Biogerontology study, female mice given Epithalon showed slower age-related changes on some markers and a lower rate of certain spontaneous tumours. Lifespan results in rodent studies have varied between experiments.[4]
The Khavinson group has also reported observational follow-up of older people given pineal peptide preparations. These studies were small, often not randomised, and published mostly by the same group, which limits how much weight they can carry.[1]
The 2025 review concludes that Epithalon shows interesting activity in cells and animals but that independent, well-controlled human trials are still missing.[5]
04 / Safety evidence
Safety and open questions
Published reports have not described serious adverse effects, but the 2025 review notes that the evidence base is too small and too concentrated to establish safety with confidence.[5]
Because increased telomerase activity is also a feature of many cancer cells, researchers note that long-term effects of telomerase activation need careful study. This remains an open question rather than a known risk or benefit.[5]
Most data come from one research school. Independent replication is the main gap in the literature.
05 / Regulators
Regulatory status
Epithalon is not an approved medicine in the UAE, the United States, or the European Union. Some pineal peptide products have been registered in Russia, as noted in the review literature, but this does not equal approval elsewhere.[5]
In the UAE, the Emirates Drug Establishment maintains the public registered medical product directory. This guide does not use directory presence or absence to infer approval, legality, or permission for use; those questions require confirmation from the EDE. Afiya Labs lists Epithalon strictly as a laboratory research reference material.[6]
06 / Quick answers
Frequently asked questions
Is it Epithalon or Epitalon?
Both spellings refer to the same tetrapeptide, Ala-Glu-Asp-Gly. Epitalon is common in the scientific literature; Epithalon is common elsewhere.
Does Epithalon lengthen telomeres in people?
That has not been shown in independent human trials. Telomerase and telomere findings come mainly from cell-culture studies.
What is epithalamin?
Epithalamin is an extract of the pineal gland studied by the Khavinson group. Epithalon is a synthetic peptide based on a sequence they associated with it.
Why is the evidence considered limited?
Most studies come from one research group, many are in animals or cells, and human studies have been small and largely uncontrolled.
Does Afiya Labs sell Epithalon for human use?
No. Afiya Labs lists Epithalon as a laboratory research reference material only. It is not a medicine and is not presented as suitable for human use.
07 / Sources
References and original records
- 1Peptide regulation of aging: 35-year research experience. Bulletin of Experimental Biology and Medicine. 2020 · Khavinson et al..
- 2Peptide Epitalon activates chromatin at the old age. Neuroendocrinology Letters. 2003 · Khavinson et al..
- 3Peptide promotes overcoming of the division limit in human somatic cell. Bulletin of Experimental Biology and Medicine. 2004 · Khavinson et al..
- 4Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. 2003 · Anisimov et al..
- 5Overview of Epitalon — highly bioactive pineal tetrapeptide with promising properties. International Journal of Molecular Sciences. 2025 · Araj et al..
- 6Registered medical product directory. UAE Emirates Drug Establishment. Official public directory · checked October 2026.